ADVATE

UNIVADIS - ADVATE /univadis/ADVATE.md

ATC

Μορφές: PS.INJ.SOL

Ημερομηνία	barcode	code	περιεχομενο	τιμή παραγωγός	χονδρική	λιανική
05/2018	2802646501013	264650101	ADVATE PS.INJ.SOL 250 IU/VIAL BTx1VIAL+1VIAL x 5ML SOLV+ΣΕΤ ΕΝΕΣΕΩΝ	187.97	197.18	238.28
05/2018	2802646502010	264650201	ADVATE PS.INJ.SOL 500 IU/VIAL BTx1VIAL+1 VIALx5ML SOLV+ΣΕΤ ΕΝΕΣΕΩΝ	375.93	381.58	444.92
05/2018	2802646503017	264650301	ADVATE PS.INJ.SOL 1000 IU/VIAL BTx1VIAL+1VIAL x5ML SOLV+ΣΕΤ ΕΝΕΣΕΩΝ	751.88	763.17	861.55
05/2018	2802646504014	264650401	ADVATE PS.INJ.SOL 1500 IU/VIAL BTx1VIAL+1VIAL x5ML SOLV+ΣΕΤ ΕΝΕΣΕΩΝ SOLV+ΣΕΤ ΕΝΕΣΕΩΝ	1127.81	1144.75	1274.11
05/2018	2802646505011	264650501	ADVATE PS.INJ.SOL 2000IU/VIAL BTx1VIAL+1VIAL x5ML SOLV+ΣΥΣΚΕΥΗ ΑΝΑΣΥΣΤΑΣΗΣ	1503.74	1526.33	1678.58
05/2018	2802646506018	264650601	ADVATE PS.INJ.SOL 3000IU/VIAL BTx1VIAL+1VIAL x5ML SOLV+ΣΥΣΚΕΥΗ ΑΝΑΣΥΣΤΑΣΗΣ SOLV+ΣΥΣΚΕΥΗ ΑΝΑΣΥΣΤΑΣΗΣ	2255.62	2289.50	2493.61

DRUGBANK - Antihemophilic Factor
indication:
For the treatment of hemophilia A, von Willebrand diseae and Factor XIII deficiency
pharmacology:
mechanism:
Antihemophilic factor (AHF) is a protein found in normal plasma which is necessary for clot formation. The administration of AHF provides an increase in plasma levels of AHF and can temporarily correct the coagulation defect of patients with hemophilia A (classical hemophilia).
toxicity:
absorprion:
halflife:
8.4-19.3 hrs
roouteelimination:
volumedistribution:
clearance:
* 4.1 mL/h•kg [Previously treated pediatric patients]